Pondé, Noam
Aftimos, Philippe
Piccart, Martine
Article History
First Online: 1 April 2019
Compliance with Ethical Standards
:
: Noam Pondé has received travel support from Roche/Genentech, Janssen-Cilag, and Mundipharma, as well as speaker’s fees from Mundipharma. The institute he works for has received research funding from AstraZeneca, Lilly, MSD, Novartis, Pfizer, Roche-Genentech, Synthon, Radius, and Servier. Philippe Aftimos has received travel support from Roche, MSD, and Amgen; consulting fees from Synthon, Boehringer/Ingleheim, and Macrogenics; and speaker Fees from Amgen and Novartis. The institute he works for has received research funding from AstraZeneca, Lilly, MSD, Novartis, Pfizer, Roche-Genentech, Synthon, Radius, and Servier. Martine Piccart is a board member of Radius. She has received honoraria as a consultant from AstraZeneca, Lilly, MSD, Novartis, Odonate, Pfizer, Roche-Genentech, Camel-IDS, Crescendo Biologics, Periphagen, Huya, Debiopharm, PharmaMar, G1 Therapeutics, Menarini, Seattle Genetics, Immunomedics, and Oncolytics. Her institute has received research funding from AstraZeneca, Lilly, MSD, Novartis, Pfizer, Roche-Genentech, Synthon, Radius, and Servier.
: This article does not contain any studies with human or animal subjects performed by any of the authors.